Skip to content

Evaluation of task-extraction and acceptability of an artificial intelligence decision model for beginning a cancer risk-judgement service

Evaluation of task-extraction and acceptability of an artificial intelligence decision model for beginning a cancer risk-judgement service - Evaluation of task-extraction and acceptability of an artificial intelligence decision model for beginning a cancer risk-judgement service

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000049611
Enrollment
30
Registered
2023-12-01
Start date
2022-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy male/female adults

Interventions

None listed

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy male/female subjects, not less than twenty years old at informed consent. (2) Subjects being under the conditions described below: Suffering from colon cancer, and for the duration of their follow-up period (except anticancer drug therapy) or completed their period. Suffering from other cancers (except colon one), and for the duration of their follow-up period (except anticancer drug therapy). (3) Subjects who can give informed consent to take part in this research, after being provided with an explanation of the protocol detail.

Exclusion criteria

Exclusion criteria: (1) Subjects being under some kind of continuous medical treatment (e.g., diabetes mellitus, heart/liver/kidney/mental disease). (2) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.

Design outcomes

Primary

MeasureTime frame
Blood-miRNA analysis, blood biochemical tests, hematologic tests, and Brief-type self-administrated Diet History Questionnaire (BDHQ)

Countries

Japan

Contacts

Public ContactMasanori Numa

CPCC Company Limited Clinical Planning Department

cpcc-contact@cpcc.co.jp03-6225-9001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026